CTA-PB

E. I. du Pont de Nemours and Company
CAPPED RATING

E. I. du Pont de Nemours and Company provides seeds and crop protection products for the agriculture industry in the United States, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. It operates through Seed and Crop Protection segments. The Seed segment develops and supplies advanced germplasm and traits that produce yield for farms; offers corn, soybean, and other oil seeds; trait technologies that enhance resistance to weather, disease, insects, and herbicides, which is used to control weeds. It also enhances food and nutritional characteristics; and digital solutions that assist farmer decision-making with a view to optimizing product selection and yield. The Crop Protection segment serves the agricultural input industry with products that protect against weeds, insects and other pests, and diseases, as well as enhance overall crop health above and below ground via nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers and pasture, and range management herbicides. In addition, it offers its products under the Pioneer, Brevant, Dairyland Seed, Hoegemeyer, Nutech, Seed Consultants, AgVenture, Alforex, PhytoGen, Pannar, VP Maxx, HPT, G2, Supreme EX, XL, Power Plus, ENLIST E3, ENLIST, EXZACT, HERCULEX, Leptra, POWERCORE, Optimum, AcreMax, REFUGE ADVANCED, SMARTSTAX, NEXERA, Omega-9 Oils, AQUAmax, Plenish, ExpressSun, Protector, Pioneer MAXIMUS, Qrome, Clearfield, PROPOUND, Conkesta, Conkesta E3, WideStrike, LumiGEN, LUMIDERM, LUMIVIA, LUMIALZA, GRANULAR, ACREVALUE, Granular, and Insights brand names. The company was founded in 1802 and is headquartered in Wilmington, Delaware. E. I. du Pont de Nemours and Company is a subsidiary of Corteva, Inc.

E. I. du Pont de Nemours and Company (CTA-PB) is rated C (2.3/5) on Deltasharpe Prism, scored against General sector peers. Its strongest pillar is Profitability (B-); its weakest is Revisions (D+). The rating has held at C for 82 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.3 / 5.0
C
Value
C+
Factor Score 2.7 / 5.0
Growth
C
Factor Score 2.3 / 5.0
Profitability
B-
Factor Score 2.9 / 5.0
Momentum
C-
Factor Score 2.1 / 5.0
Revisions
D+
Factor Score 1.5 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio 34.1
EV / EBITDA 24.4
Rev Growth YoY 5.6%
Gross Margin 54.6%
Price Return 3M -2.6%
Price Return 12M 0.6%
Catalyst Signal 0.00
Market Cap N/A
TTM Revenue N/A
Price / Sales 7.0
ROE 5.0%

Historical Factor Score Progression

Held C for 82 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-07-29 C+ (2.7) C (2.3) B- (2.9) C- (2.1) D+ (1.5) C (2.3)
2025-06-30 C+ (2.7) C (2.3) B- (3.0) C- (2.1) D+ (1.5) C (2.3)
2025-03-31 C+ (2.7) C- (2.0) C+ (2.8) C- (2.1) D+ (1.5) C (2.2)
2024-12-31 C+ (2.6) C (2.4) C+ (2.5) C- (2.1) D (1.5) C (2.2)
2024-09-30 C+ (2.6) D+ (1.6) C (2.4) C- (2.1) D+ (1.5) C- (2.0)
Page 1 of 5